Nov 12 (Reuters) - Collegium Pharmaceutical Inc COLL.O :
* COLLEGIUM PHARMACEUTICAL INC - ON NOV 12, CO ANNOUNCED
CORPORATE
RESTRUCTURING TO SUPPORT GROWTH, PROFITABILITY OF PRODUCT
PORTFOLIO
* COLLEGIUM PHARMACEUTICAL - IN CONNECTION WITH
RESTRUCTURING, CO
IS REDUCING HEADCOUNT BY ABOUT 20%, WHICH IS EXPECTED TO BE
COMPLETED BY END OF 2021
* COLLEGIUM PHARMA - ESTIMATES TO RECORD ONE-TIME PRE-TAX
CHARGE
OF ABOUT $4 MILLION TO $5 MILLION RELATED TO RESTRUCTURING IN Q4
2021
Source text: [https://bit.ly/3n7g9FA]
Further company coverage: COLL.O
((Reuters.Briefs@thomsonreuters.com;))